Simulation-based caregiving skills training for family members of high-grade glioma patients.

Autor:	Whisenant M; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldrich E; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ownby K; Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Thomas J; Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Ngo-Huang A; Department of Palliative, Rehabilitation, & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bruera E; Department of Palliative, Rehabilitation, & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milbury K; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jazyk:	angličtina
Zdroj:	Neuro-oncology practice [Neurooncol Pract] 2024 Mar 22; Vol. 11 (4), pp. 432-440. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
DOI:	10.1093/nop/npae025
Abstrakt:	Background: Because family caregivers of patients with a high-grade glioma experience high levels of distress and feel unprepared to perform the complex caregiving tasks associated with the disease and its treatment, we pilot-tested a caregiving skills intervention that integrates hands-on caregiving with coping skill training. Methods: In this single-arm trial, caregivers participated in a 4-session research nurse-led intervention involving simulation-based caregiving skills training at the hospital and psychoeducation delivered via videoconference. We collected measures of patients' and caregivers' psychological symptoms; caregivers' caregiving self-efficacy and role adjustment; and patients' cancer-related symptoms (MDASI) at baseline and again postintervention. We tracked feasibility data. Results: We approached 29 dyads of which 10 dyads (34%) consented. All patients (mean age: 60 years, 89% male) and caregivers (mean age: 58 years, 80% female, 80% spouses) completed the baseline and 7 dyads completed the follow-up assessments (attrition was related to patient's hospice transfer). Seven caregivers completed all 4 sessions and rated the program as beneficial. Paired t -tests revealed a significant improvement in caregiving self-efficacy at 6 weeks postintervention ( t  = -3.06, P  = .02). Although improvements in caregiver role adjustment and patient and caregiver symptoms were not observed, no decreases in symptom burden or role adjustment were found during the follow-up period. Conclusions: This novel supportive care program appears to be safe, feasible, acceptable, and perceived as useful for caregivers of patients with high-grade glioma. Based on feasibility indicators and a signal of intervention efficacy, a randomized controlled trial is warranted. Competing Interests: None declared. (© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz: